Securities Code: 301367 Securities Abbreviation: Remeet Announcement No.: 2026-035 Beijing Remeet Medical Technology Co., Ltd. Announcement on the First Vesting Results of the Company's 2025 Restricted Stock Incentive Plan and Share Listing The Company and all members of the Board of Directors guarantee that the content of the information disclosed is true, accurate, and complete, and that there are no false or misleading statements or major omissions. Key Information Prompt:
- Number of eligible incentive recipients for this vesting: 52 people
- Number of restricted shares vested in this batch: 33.8569 million shares
- Source of vested shares: Company's A-share common stock repurchased from the secondary market
- Grant Price: 38.26 RMB/share (adjusted)
- Listing and circulation date of restricted shares vested in this batch: May 7, 2026. Beijing Remeet Medical Technology Co., Ltd. (hereinafter referred to as the "Company" or "this Company") held the 19th meeting of the Third Board of Directors on April 22, 2026, and reviewed and approved the "Proposal on the First Vesting Period of the Company's 2025 Restricted Stock Incentive Plan Meeting Vesting Conditions". Recently, the Company has completed the share registration for the first vesting period of the company's equity incentive plan (hereinafter referred to as the "Incentive Plan" or "this Incentive Plan"). The specific situation is announced as follows: I. Brief Introduction of the Incentive Plan and Procedures Completed (I) Brief Introduction of the Incentive Plan
- Incentive Tool: Second-class restricted shares.
- Source of Underlying Shares: Company's A-share common stock repurchased from the secondary market and/or Company's A-share common stock issued to incentive recipients.
- Grant Price: 38.26 RMB/share (adjusted).
- Scope and Allocation of Incentive Recipients: A total of 54 incentive recipients are covered by this Incentive Plan, including senior management personnel and core technical (business) personnel employed by the Company (including its holding subsidiaries, hereinafter the same) at the time of the announcement of this Incentive Plan. This plan does not include independent directors, supervisors of the Company, nor does it include shareholders or actual controllers who individually or collectively hold more than 5% of the Company's shares, nor their spouses, parents, children, and foreign employees. The details are as follows:
| Name | Position | Number of Restricted Shares Granted (million shares) | Proportion of Total Grant | Proportion of Total Share Capital at Announcement |
|---|---|---|---|---|
| 暴楠 | Deputy General Manager, Financial Controller | 2.20 | 3.13% | 0.02% |
| 郑芳 | Deputy General Manager | 2.20 | 3.13% | 0.02% |
| Core Technical (Business) Personnel (52 people) | 66.00 | 93.75% | 0.74% | |
| Total | 70.40 | 100.00% | 0.79% |
Note: (1) The shares granted to any single incentive recipient through all valid equity incentive plans do not exceed 1% of the Company's total share capital. The total number of underlying shares involved in all valid incentive plans of the Company shall not exceed 20% of the Company's total share capital at the time the Incentive Plan is submitted to the general meeting of shareholders. (2) The incentive recipients of this Incentive Plan do not include independent directors, supervisors of the Company, nor shareholders or actual controllers who individually or collectively hold more than 5% of the Company's shares, nor their spouses, parents, children, and foreign employees. (3) If the sum of the total and individual figures in the table above does not match, it is due to rounding.